GlaxoSmithKline (GSK) has announced it is to begin searching for a successor to CEO Andrew Witty, who will retire in just over a year's time. Witty has told GSK's board that he intends to retire ...
GSK also faced U.S. government investigations ... Since the assassination of his top lieutenant Brian Thompson on Dec. 4, Andrew Witty has been keeping long, difficult hours at the Minnesota ...
GSK chief executive Andrew Witty told investors yesterday that Advair/Seretide sales are likely to continue to decline, although he insisted that the company is starting to see "some recovery in ...
Andrew Witty became CEO of UnitedHealth Group in 2021, but this isn’t his first medical executive gig—he also served as CEO of leading pharmaceutical manufacturer GlaxoSmithKline from 2008 to ...
The big picture: UnitedHealth Group CEO Andrew Witty spoke at length Thursday about ... The intrigue: Witty is a former CEO of British drug company GSK. During his tenure there, he told CNBC ...
In an interview with WSJ's Dennis Berman, GlaxoSmithKline CEO Andrew Witty discusses why the drug maker has devoted time to researching a malaria vaccine for children in Africa -- and why he ...